國立高雄大學圖資館 |

Language: English

Back

CNS drug development and deliveryconcepts and applications /

Record Type:	Electronic resources : Monograph/item
Title/Author:	CNS drug development and deliveryedited by Alan Talevi.
Reminder of title:	concepts and applications /
other author:	Talevi, Alan.
Published:	Cham :Springer Nature Switzerland :2024.
Description:	vii, 230 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Central nervous systemChemotherapy.
Online resource:	https://doi.org/10.1007/978-3-031-62604-3
ISBN:	9783031626043$q(electronic bk.)

CNS drug development and deliveryconcepts and applications /
CNS drug development and deliveryconcepts and applications /[electronic resource] :edited by Alan Talevi. - Cham :Springer Nature Switzerland :2024. - vii, 230 p. :ill. (some col.), digital ;24 cm. - AAPS introductions in the pharmaceutical sciences,v. 99992522-8358 ;. - AAPS introductions in the pharmaceutical sciences ;v. 9..

Chapter 1- Transporter-mediated drug delivery to the brain -- Chapter 2 - Mechanisms and methods for evaluating drug delivery via transcytosis to the brain -- Chapter 3 -In vitro blood-brain studies -- Chapter 4 - In silico prediction of CNS bioavailability -- Chapter 5 - Use of unbound exposure data to establish in vitro-in vivo correlations for CNS drug candidates -- Chapter 6 - Intranasal Delivery of Drugs to the Central Nervous System -- Chapter 7 - Polymeric nanoparticles for nose-to-brain delivery in Alzheimer's and Parkinson's diseases -- Chapter 8 - Barriers of the CNS and their contribution to drug-resistant epilepsy -- Chapter 9 - Network-pharmacology and central nervous system drug development.

The book covers recent advances in the field of CNS therapeutics, including opportunities posed by expanding basic knowledge related to CNS conditions and novel approaches for efficient drug delivery to the brain (e.g., pharmaceutical nanocarriers and transporter- and transcytosis-mediated drug delivery to the brain inhibition of the blood-brain barrier) Chapters dealing with state-of-the-art in silico and in vitro tools for predictive purposes related to CNS bioavailability are also be included. This is an ideal book for undergraduate students and graduates in the field of medicine and pharmaceutics, and professionals working in the field of brain disorders.

ISBN: 9783031626043$q(electronic bk.)

Standard No.: 10.1007/978-3-031-62604-3doiSubjects--Topical Terms:

897373
Central nervous system
--Chemotherapy.

LC Class. No.: RC361

Dewey Class. No.: 615.78

CNS drug development and deliveryconcepts and applications /
LDR:02520nmm a2200361 a 4500 001 666500
003 DE-He213
005 20240713130857.0
006 m d
007 cr nn 008maaau
008 250107s2024 sz s 0 eng d
020 $a 9783031626043$q(electronic bk.)
020 $a 9783031626036$q(paper)
024 7 $a 10.1007/978-3-031-62604-3 $2 doi
035 $a 978-3-031-62604-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC361
072 7 $a MMG $2 bicssc
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
072 7 $a MKG $2 thema
082 0 4 $a 615.78 $2 23
090 $a RC361 $b .C651 2024
245 0 0 $a CNS drug development and delivery $h [electronic resource] : $b concepts and applications / $c edited by Alan Talevi.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a vii, 230 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a AAPS introductions in the pharmaceutical sciences, $x 2522-8358 ; $v v. 9999
505 0 $a Chapter 1- Transporter-mediated drug delivery to the brain -- Chapter 2 - Mechanisms and methods for evaluating drug delivery via transcytosis to the brain -- Chapter 3 -In vitro blood-brain studies -- Chapter 4 - In silico prediction of CNS bioavailability -- Chapter 5 - Use of unbound exposure data to establish in vitro-in vivo correlations for CNS drug candidates -- Chapter 6 - Intranasal Delivery of Drugs to the Central Nervous System -- Chapter 7 - Polymeric nanoparticles for nose-to-brain delivery in Alzheimer's and Parkinson's diseases -- Chapter 8 - Barriers of the CNS and their contribution to drug-resistant epilepsy -- Chapter 9 - Network-pharmacology and central nervous system drug development.
520 $a The book covers recent advances in the field of CNS therapeutics, including opportunities posed by expanding basic knowledge related to CNS conditions and novel approaches for efficient drug delivery to the brain (e.g., pharmaceutical nanocarriers and transporter- and transcytosis-mediated drug delivery to the brain inhibition of the blood-brain barrier) Chapters dealing with state-of-the-art in silico and in vitro tools for predictive purposes related to CNS bioavailability are also be included. This is an ideal book for undergraduate students and graduates in the field of medicine and pharmaceutics, and professionals working in the field of brain disorders.
650 0 $a Central nervous system $x Chemotherapy. $3 897373
650 0 $a Neuropsychopharmacology. $3 229903
650 0 $a Drug delivery systems. $3 196465
650 1 4 $a Pharmacology. $3 218135
650 2 4 $a Neuropharmacology. $3 275141
650 2 4 $a Drug Delivery. $3 911847
650 2 4 $a Pharmaceutics. $3 913065
700 1 $a Talevi, Alan. $3 826330
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a AAPS introductions in the pharmaceutical sciences ; $v v. 9. $3 943878
856 4 0 $u https://doi.org/10.1007/978-3-031-62604-3
950 $a Biomedical and Life Sciences (SpringerNature-11642)